Overcoming therapeutic resistance in malignant gliomas: current practices and future directions.

Cancer treatment and research

Volumn 139, Issue , 2008, Pages 173-189

  Chakravarti, Arnab ^a   Palanichamy, Kamalakannan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ANIMAL; BRAIN TUMOR; CLINICAL TRIAL; DRUG RESISTANCE; GLIOMA; HUMAN; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RADIOTHERAPY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; RADIATION TOLERANCE; RADIOTHERAPY;

MLCS; MLOWN;

EID: 40049100067     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-0-387-36744-6_9     Document Type: Review

References (63)